Boiron SA

Rentabilité sur six mois: 0%
Rendement en dividendes: 0%
Secteur: Healthcare

35.85 $

0 $ 0%
34.5 $
35.85 $

paper.min_max_per_year

Calendrier des promotions Boiron SA

À propos de l'entreprise Boiron SA

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; Sédatif PC to treat anxiety and emotional, and minor sleep disorders; Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; Homéovox for vocal disorders; Homéoplasmine for treating irritated skin and redness; Varésol to treat symptoms of chickenpox; and Arnicare Arthritis for use in the treatment of benign trauma pain. In addition, it offers Dermoplasmine, a plant based multi-use balm that repairs and protects irritated and damaged skin; COVID self-tests and rapid antigenic tests; LABIAMEO, that used to treat outbreaks of localized cold sores; and CONVAMEO to treat physical and mental asthenia. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.

Paramètres de base

Industry
Pharmaceuticals
Sector
Health Care
Валюта
usd
Валюта отчета
eur
Див.доход ао
3.41
Дивиденд ао
1.26
Сайт

Grade

Sous-estimation
Nom Signification Grade
P/S 1.36 9
P/BV 1.71 8
P/E 18.69 7
Efficacité
Nom Signification Grade
ROA 6.07 2
ROE 9.1 3
ROIC 0 0
Dividendes
Nom Signification Grade
Rendement en dividendes 0 0
DSI 0.5714 5.71
Croissance moyenne du dividende -58.41 0
Devoir
Nom Signification Grade
Debt/EBITDA 0.1148 10
Debt/Ratio 0.0127 10
Debt/Equity 0.5075 9
Impulsion de croissance
Nom Signification Grade
Rentabilité Revenue, % -11.47 0
Rentabilité Ebitda, % -40.88 0
Rentabilité EPS, % -19.14 0

paper.price.prices

Prix Common.min. Common.max. Changement paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 35.85 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.7d 35.85 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.30d 35.85 $ 35.85 $ 35.85 $ 0 % 0 % 0 %
common.calendar.number_days.90d 35.85 $ 35.85 $ 35.85 $ 0 % 0 % 0 %
common.calendar.number_days.180d 35.85 $ 35.85 $ 35.85 $ 0 % 0 % 0 %
common.calendar.number_days.1y 35.85 $ 34.5 $ 35.85 $ 0 % 0 % 0 %
common.calendar.number_days.3y 44.5 $ 32.9 $ 53.5 $ -19.44 % 0 % 0 %
common.calendar.number_days.5y 32.9 $ 32.9 $ 53.5 $ 108.97 % 0 % 0 %
common.calendar.number_days.10y 30 $ 30 $ 99.25 $ 119.5 % 0 % 0 %
common.calendar.number_days.ytd 35.85 $ 35.85 $ 35.85 $ 0 % 0 % 0 %

Principaux propriétaires

Entreprises similaires



Gestion d'entreprise

Superviseur Titre d'emploi Paiement Année de naissance
Mr. Jean-Christophe Bayssat Deputy GM, Chief Pharmacist & Director of Pharmaceutical Development 441.18k 1963 (62 année)
Mr. Eric Lambert Secretary General and Chief Financial & Administrative Officer N/A
Mr. Patrice Varraut Director of Operations N/A
Ms. Juliette Baudry Human Resources Director N/A
Fabrice Rey Group Treasurer N/A
Mr. Thierry Boiron GM & Director 1961 (64 année)

Informations sur l'entreprise

Adresse: France, Messimy, 2 avenue de l’Ouest Lyonnais - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.boiron.fr